Renal Disease

Disease State Hub

Podcasts

NUTRITION411: THE PODCAST, EP. 45

Advanced Nutritional Strategies for Patients With Renal Disorders

10/25/2024

Lisa Jones, MA, RDN, LDN, FAND

In this podcast episode, Lisa Jones, MA, RDN, LDN, FAND, interviews Kimberly Snodgrass, RDN, LD, FAND, a renal care coordinator at Fresenius Medical Care, on advanced nutritional strategies that dietitians...

10/25/2024

Nutrition411: The Podcast, Ep. 44

Navigating the Challenges of Dietary Management in Patients With Common Renal Conditions

10/17/2024

Lisa Jones, MA, RDN, LDN, FAND

In this podcast episode, Lisa Jones, MA, RDN, LDN, FAND, interviews Kimberly Snodgrass, RDN, LD, FAND, a renal care coordinator at Fresenius Medical Care, on how dietitians can effectively address some...

10/17/2024

Podcast

The Role, Benefits, and Challenges of Urgent-Start Peritoneal Dialysis

01/24/2024

In part 1 of this 2-part episode, James Matera, DO, FACOI, speaks about the role, benefits, and challenges of urgent-start peritoneal dialysis in adults and children with chronic kidney disease...

01/24/2024

Podcast

Infrastructure Required for Urgent-Start Peritoneal Dialysis

03/23/2023

In part 2 of this 2-part episode, James Matera, DO, FACOI, speaks about the infrastructure required for urgent-start peritoneal dialysis (PD) and the urgent-start PD clinical pathway from patient...

03/23/2023

Diabetes

Food Insecurity, Diabetes, and Cardiorenal Syndrome

10/29/2022

In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, speaks about his research on the association between food insecurity, cardiorenal syndrome, and all-cause mortality among low-income adults in the United...

10/29/2022

Cardiometabolic Risk

George Bakris, MD, on the Renal Outcomes From the CREDENCE Trial

04/16/2022

In this podcast, George Bakris, MD, from the University of Chicago, talks about the renal outcomes from the Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in...

04/16/2022

Research Summaries

Research Summary

Lumasiran Shows Efficacy, Plasma Oxalate Reductions for Patients With Primary Hyperoxaluria, Severe Renal Impairment at 24 Months

06/20/2024

Anthony Calabro, MA

In the ILLUMINATE-C trial, patients with advanced primary hyperoxaluria type 1 and severe renal impairment treated with lumasiran showed decreased plasma oxalate and good safety profiles at 6 months and 12...

06/20/2024

FDA ALERT

FDA Approves Nedosiran for Patients 9 Years of Age and Older With Primary Hyperoxaluria Type 1

01/29/2024

Anthony Calabro, MA

The once-monthly RNA interference injection medication received FDA approval based on results from the phase II PHYOX2 clinical trial and phase III PHYOX3 extension study.

01/29/2024

Endocrinology

FDA Approves New Drug for Cushing Disease

03/09/2020

The new treatment is the first FDA-approved drug to address the overproduction of cortisol in Cushing disease by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis.

03/09/2020

Renal Disease

Model Predicts ESLD Among Patients with HIV

03/08/2019

A predictive model could be used to help risk of end-stage liver disease in people living with HIV, according to recent research.

03/08/2019

Kidney Disease

Childhood Kidney Disease May Raise Adulthood ESRD Risk

02/01/2018

The authors of a new study investigated the long-term risk for adulthood end-stage renal disease among individuals who had childhood kidney disease that resolved prior to adolescence.

02/01/2018

November 2024

Current Issue

November 2024